Advanced methods for SARS-CoV-2 detection and characterisation

09:30 • 2430 • Reverse transcription digital PCR (RT-dPCR) can be used to characterise materials for quality control of molecular diagnostic methods that target different RNA fragment sizes within the SARS-CoV-2 genome > D. Denise O'SULLIVAN (Middlesex) 09:35 • 1339 • Responding to the COVID-19 pandemic: optimise molecular diagnostics in clinical laboratories > L. Libera CLEMENTE (Trieste) 09:40 • 1407 • Diagnostic evaluation of rapid antigen tests (RATs) for SARS-CoV-2: RATs' efficiency level in monitoring the infectiousness of COVID-19 patients > M. Maria MAVROULI (Athens) 09:45 • 2520 • Quantification of SARS-CoV-2 by clinical metagenomics > J. John ROSSEN (Salt Lake City) 09:50 • 2530 • Target capture sequencing of SARS-CoV-2 genomes from COVID-19 patients in Florida, USA > S. Shing ZHAN (Burnaby) 09:55 • 3308 • Correlation between SARS-CoV-2 subgenomic RNA and viral culture > M. Marta SANTOS BRAVO (Barcelona) 10:00 • 3806 • Mutations in the SARS-CoV-2 S-gene close to the del69/70 can produce misleading results in mutation specific PCR protocols > M. Marion DUSEK (Berlin) 10:05 • 4431 • Performance of VirSNP SARS-CoV-2 Spike N501Y and VirSNP SARS-CoV-2 Spike del H69/V70 (TIB Molbiol) compared to WGS of SARS-CoV-2 to detect Variant of Concern 202012/01 (VOC-202012/01) > M. Marijke RAYMAEKERS (Hasselt) 10:10 • 4474 • Alternative sampling strategies for SARS-CoV-2 diagnosis: assessment of agreement and analysis of real-time RT-PCR cycle threshold results > L. Laura BUBBA (Milan) 10:15 • 4538 • Validation of the TaqMan® SARS-CoV-2 Mutation Assays for the rapid detection and discrimination of SARS-CoV-2 variants of concern > S. Sunita JANSSENSWILLEN (Leuven) 10:20 • INT95 • Q&A/Discussion